HIMS:NYE-Hims Hers Health Inc (USD)

COMMON STOCK | Household & Personal Products |

Last Closing

USD 11.26

Change

0.00 (0.00)%

Market Cap

USD 2.99B

Volume

0.01B

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-04 )

Largest Industry Peers for Household & Personal Products

Symbol Name Price(Change) Market Cap
UL Unilever PLC ADR

N/A

USD 152.88B
KMB Kimberly-Clark Corporation

N/A

USD 45.65B
CHD Church & Dwight Company Inc

N/A

USD 25.11B
CLX The Clorox Company

N/A

USD 20.11B
COTY Coty Inc

N/A

USD 6.60B
ELF ELF Beauty Inc

N/A

USD 6.22B
SPB Spectrum Brands Holdings Inc

N/A

USD 2.51B
EPC Edgewell Personal Care Co

N/A

USD 1.73B
PZC PIMCO California Municipal Inc..

N/A

USD 0.63B
YSG Yatsen Holding

N/A

USD 0.38B

ETFs Containing HIMS

EDOC:LSE Global X Telemedicine & D.. 4.72 % 0.00 %

N/A

USD 3.69M
EDOC:SW Global X Telemedicine & D.. 4.40 % 0.00 %

N/A

N/A
EDOG:LSE Global X Telemedicine & D.. 4.38 % 0.00 %

N/A

USD 0.38M
EDOC:AU BetaShares Digital Health.. 4.23 % 0.00 %

N/A

N/A
EDOC Global X Telemedicine & D.. 3.81 % 0.00 %

N/A

USD 0.04B
FDOC:LSE Fidelity Digital Health U.. 3.49 % 0.00 %

N/A

USD 3.02M
XHS SPDR® S&P Health Care Se.. 2.83 % 0.35 %

N/A

USD 0.08B
RTWO:LSE L&G Russell 2000 US Small.. 0.60 % 0.00 %

N/A

USD 0.15B
RTWP:LSE Legal & General UCITS ETF.. 0.60 % 0.00 %

N/A

USD 0.15B
ETLZ:XETRA L&G Russell 2000 US Small.. 0.60 % 0.00 %

N/A

USD 0.09B
FFTY Innovator IBD® 50 ETF 0.00 % 0.80 %

N/A

N/A
IBUY Amplify Online Retail ETF 0.00 % 0.65 %

N/A

USD 0.17B
PSC Principal U.S. Small-Cap .. 0.00 % 0.38 %

N/A

USD 0.66B

Market Performance

  Market Performance vs. Industry/Classification (Household & Personal Products) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 26.52% 100% F 95% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 26.52% 100% F 95% A
Trailing 12 Months  
Capital Gain -6.48% 44% F 21% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -6.48% 44% F 18% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 11.01% 78% C+ 73% C
Dividend Return 11.01% 78% C+ 67% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 54.88% 17% F 16% F
Risk Adjusted Return 20.06% 50% F 43% F
Market Capitalization 2.99B 44% F 70% C-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.